Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1988 1
1990 1
1996 1
1997 1
1999 4
2000 5
2001 1
2002 4
2003 4
2004 6
2005 7
2006 7
2007 8
2008 12
2009 11
2010 19
2011 29
2012 18
2013 24
2014 17
2015 8
2016 8
2017 12
2018 10
2019 8
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

193 results
Results by year
Filters applied: . Clear all
Page 1
The Human Bitumen Study: executive summary.
Raulf-Heimsoth M, Pesch B, Rühl R, Brüning T. Raulf-Heimsoth M, et al. Among authors: pesch b. Arch Toxicol. 2011 Jun;85 Suppl 1:S3-9. doi: 10.1007/s00204-011-0679-0. Epub 2011 Mar 3. Arch Toxicol. 2011. PMID: 21369765 Review.
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
Benderska-Söder N, Hovanec J, Pesch B, Goebell PJ, Roghmann F, Noldus J, Rabinovich J, Wichert K, Gleichenhagen J, Käfferlein HU, Köhler CU, Johnen G, Kernig K, Hakenberg O, Jahn D, Todenhöfer T, Stenzl A, Gleissner J, Gerwert K, El-Mashtoly S, Behrens T, Brüning T, Schmitz-Dräger BJ. Benderska-Söder N, et al. Among authors: pesch b. Urol Oncol. 2020 Dec;38(12):886-895. doi: 10.1016/j.urolonc.2020.01.006. Epub 2020 Mar 18. Urol Oncol. 2020. PMID: 32199755 Review.
NAT2 and bladder cancer--response.
Pesch B, Bruening T, Vineis P. Pesch B, et al. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):562. doi: 10.1158/1055-9965.EPI-13-1349. Epub 2013 Dec 31. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24381185 Free article. No abstract available.
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report.
Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, Kogevinas M, Kogi K, Lie JA, Lowden A, Peplonska B, Pesch B, Pukkala E, Schernhammer E, Travis RC, Vermeulen R, Zheng T, Cogliano V, Straif K. Stevens RG, et al. Among authors: pesch b. Occup Environ Med. 2011 Feb;68(2):154-62. doi: 10.1136/oem.2009.053512. Epub 2010 Oct 20. Occup Environ Med. 2011. PMID: 20962033
Gendered work-family trajectories and depression at older age.
Engels M, Weyers S, Moebus S, Jöckel KH, Erbel R, Pesch B, Behrens T, Dragano N, Wahrendorf M. Engels M, et al. Among authors: pesch b. Aging Ment Health. 2019 Nov;23(11):1478-1486. doi: 10.1080/13607863.2018.1501665. Epub 2019 Jan 9. Aging Ment Health. 2019. PMID: 30621439
Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.
Kamat AM, Vlahou A, Taylor JA, Hudson ML, Pesch B, Ingersoll MA, Todenhöfer T, van Rhijn B, Kassouf W, Barton Grossman H, Behrens T, Chandra A, Goebell PJ, Palou J, Sanchez-Carbayo M, Schmitz-Dräger BJ. Kamat AM, et al. Among authors: pesch b. Urol Oncol. 2014 Oct;32(7):1069-77. doi: 10.1016/j.urolonc.2014.06.017. Epub 2014 Oct 11. Urol Oncol. 2014. PMID: 25306288 Review.
Calretinin as a blood-based biomarker for mesothelioma.
Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Brüning T, Creaney J. Johnen G, et al. Among authors: pesch b. BMC Cancer. 2017 May 30;17(1):386. doi: 10.1186/s12885-017-3375-5. BMC Cancer. 2017. PMID: 28558669 Free PMC article.
193 results